nav-left cat-right
cat-right

Biomarker Summit Europe 2015 on October 5-8, 2015 ...

The summit will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of clinical translation, novel technologies including next-generation sequencing, regulatory and reimbursement issues and companion diagnostics. Scientific data, case studies and...

2nd Next Generation Sequencing: Opportunities ...

We are pleased to invite you to the 2nd Next Generation Sequencing: Opportunities & Challenges Conference, which will take place October 7-8, 2015 in Berlin, Germany. The conference will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research happening. This conference is...

2nd Bioinformatics & Drug Discovery Conferenc...

We are pleased to invite you to the 2nd Bioinformatics & Drug Discovery Conference, which will take place October 5-6, 2015 in Berlin, Germany. The conference will bring together the world’s leading bioinformaticians and discuss developments in NGS big data, cloud systems, clinical and cancer genomics data, and database integration. This conference is part our larger Technologies in Drug Discovery Summit Europe which...

Technologies in Drug Discovery Summit Europe Octob...

We are pleased to invite you to the Technologies in Drug Discovery Summit Europe, which will take place October 5-8, 2015 in Berlin, Germany. The summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research happening. Technologies in Drug Discovery Summit Europe will...

Companion Diagnostics Conference June 11-12, 2015,...

GTCbio invite you to the Companion Diagnostics Conference, which takes place June 11-12, 2015 in San Diego, CA at the Hyatt Regency Mission Bay. CDx play a significant role in the area of personalized medicine for viral diseases and drug development. There are opportunities and limitations in companion diagnostics and its combination with next generation sequencing towards targeted therapeutic areas. Join fellow researchers...

Point-of-Care Diagnostics Conference June 11-12, 2...

GTCbio invite you to attend the Point-of-Care Diagnostics Conference, which will take place on June 11-12, 2015 in San Diego, CA at the Hyatt Regency Mission Bay. The development of accurate POC testing and its impact on new disease areas and disease management presents many challenges for healthcare providers and manufacturers. Regulatory aspects, validation, clinical applications must be considered when discussing the...

FLEXYTE® assays harness the power and potential of...

Melbourn, UK and Craigavon, Northern Ireland, UK (5th February 2015) – A strategic alliance has been formed for the marketing and sale of a complete fluorescence lifetime (FLT) technology comprising Almac Group’s proprietary FLEXYTE® FLT reagents and assays, and TTP Labtech’s new ameon® microplate reader. Customers can now gain full access to support, and buy equipment and essential reagents all from TTP Labtech,...

XL-protein Signs Licensing Agreement with MSD Anim...

FREISING, GERMANY, February 12, 2015 – XL-protein GmbH, Germany, a privately owned biopharmaceutical company, announced today that they have entered into a license agreement with MSD Animal Health (known as Merck Animal Health in the USA and Canada) to develop PASylated biopharmaceuticals for use in animal health. This license agreement follows a research collaboration between the two companies which began in 2012 and...

Zedira receives further funding to develop Factor ...

Zedira has received further funding from the German Federal Ministry for Education and Research (German abbreviation: BMBF). The project volume has been extended by € 1.0 Mio. so that the total project value exceeds € 5.0 Mio. by now. The additional funding will allow completing the development of a drug candidate for „safe“ anticoagulation. Zedira targets coagulation factor XIIIa (F13, plasma transglutaminase) using...

Polypropylene PCR plates from Porvair Sciences Ltd

To ensure full compatibility with robotic systems, DNase / RNase- and pyrogen-free PCR plates from Porvair Sciences feature high rigidity to minimise distortion before and after thermal cycling. Produced in Class 10,000 clean room conditions – Porvair range of PCR plates are certified free of pyrogens as well as DNAse and RNAse enzyme activity enabling routine achievement of excellent PCR results. Porvair PCR plates are...
Page 1 of 13412345...102030...Last »